Rephonic
Artwork for OncLive® On Air

OncLive® On Air

OncLive® On Air
Breast Cancer
Small Cell Lung Cancer
Immunotherapy
Non-Small Cell Lung Cancer
Multiple Myeloma
Clinical Trials
Chronic Myeloid Leukemia
Triple Negative Breast Cancer
Chronic Lymphocytic Leukemia
Antibody Drug Conjugates
Oncology
Hr-Positive Her2-Negative Metastatic Breast Cancer
Pembrolizumab
Biomarker Testing
ESR1 Mutations
Triple-Negative Breast Cancer
Prostate Cancer
Her2-Positive Breast Cancer
KRAS
PARP Inhibitors

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

PublishesDailyEpisodes500Founded8 years ago
Number of ListenersCategories
Health & FitnessScience

Listen to this Podcast

Artwork for OncLive® On Air

Latest Episodes

In our exclusive interview, Dr Haddad discussed the importance of consistent daily adherence to oral TKIs for achieving deep responses, treatment-free remission, and long-term survival in patients with CML. Additionally, he broke down common barriers... more

In today’s episode, we spoke with Nathan A. Boggs, MD, PhD, about the role the allergists play in the diagnosis and management of systemic mastocytosis. Dr Boggs is the director of the Allergy Division in the School of Medicine of Uniformed Services ... more

Two Onc Docs, hosted by Samantha A. Armstrong, MD, and Karine Tawagi, MD, is a podcast dedicated to providing current and future oncologists and hematologists with the knowledge they need to ace their boards and deliver quality patient care. Dr Armst... more

In this episode of OncLive On Air, Aditya Juloori, MD, a radiation oncologist and associate professor at the University of Chicago in Illinois, was joined by David Carbone, MD, PhD, a thoracic medical oncologist and director of the Thoracic Oncology ... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

David Carbone
Thoracic medical oncologist and director of the Thoracic Oncology Center at The Ohio State University
The Ohio State University
Episode: S19 Ep13: Beyond PD-L1: Refining First-Line Treatment Decisions in Metastatic NSCLC
Lyudmila Bazhenova
Thoracic medical oncologist and co-lead of the lung cancer team at UC San Diego Moores Cancer Center
UC San Diego Moores Cancer Center
Episode: S19 Ep12: Order Both IHC and NGS: Defining MET Alterations and Positioning Telisotuzumab Vedotin in Non–Small Cell Lung Cancer
Sandip Patel
Professor of medical oncology at UC San Diego
UC San Diego
Episode: S19 Ep12: Order Both IHC and NGS: Defining MET Alterations and Positioning Telisotuzumab Vedotin in Non–Small Cell Lung Cancer
Jacob Sands
Associate chief of the Lowe Center for Thoracic Oncology and oncology medical director of the International Patient Center
Dana-Farber Cancer Institute
Episode: S19 Ep11: Weigh Benefit Against Burden: Defining Lurbinectedin’s Role in a Shifting Small Cell Lung Cancer Landscape
Triparna Sen
Professor of internal medicine and director of the Lung Cancer Preclinical Therapeutics Platform
The Ohio State University Comprehensive Cancer Center
Episode: S19 Ep11: Weigh Benefit Against Burden: Defining Lurbinectedin’s Role in a Shifting Small Cell Lung Cancer Landscape
Erika P. Hamilton
Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute
Sarah Cannon Research Institute
Episode: S19 Ep10: FDA Approval Insights: First-Line Maintenance Tucatinib/Trastuzumab/Pertuzumab in Advanced HER2+ Breast Cancer
Jame Abraham
Enterprise chairman of hematology and medical oncology at Cleveland Clinic and professor of medicine
Cleveland Clinic
Episode: S19 Ep9: Biology-Driven Care and AI Tools Steer the Future of Breast Oncology
Beth Faiman
Adult nurse practitioner in hematology and oncology at Cleveland Clinic
Cleveland Clinic
Episode: S19 Ep8: Subcutaneous, On-Body Administration Opens Potential Door for At-Home Treatment in Multiple Myeloma
Sikander Ailawadhi
Professor of medicine and consultant in hematology and oncology at Mayo Clinic
Mayo Clinic
Episode: S19 Ep8: Subcutaneous, On-Body Administration Opens Potential Door for At-Home Treatment in Multiple Myeloma

Reviews

4.5 out of 5 stars from 34 ratings
  • Best option for CME podcasts

    Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!

    Apple Podcasts
    5
    Dlshaka
    United Statesa year ago
  • My favorite podcast for oncology

    This podcast provides excellent information to anyone who works in the medical field on oncology.

    Apple Podcasts
    5
    Chiliman1986
    United States7 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners value data-driven discussion and expert guest diversity.
Great CME content for clinicians and researchers.
High-quality oncology insights and practical takeaways.

Talking Points

Recent interactions between the hosts and their guests.

S18 Ep45: Advancing Targeted Therapy in HR+/HER2– Metastatic Breast Cancer: Integrating Next-Generation Endocrine and PAM-Pathway Strategies Into Practice
Q: When would you perform ESR1 mutation testing using circulating tumor DNA during first-line endocrine therapy?
The panel favors using serial testing to identify emerging ESR1-mediated resistance before radiographic progression, while noting that testing frequency, routine access, and financial toxicity must be considered.
S18 Ep45: Advancing Targeted Therapy in HR+/HER2– Metastatic Breast Cancer: Integrating Next-Generation Endocrine and PAM-Pathway Strategies Into Practice
Q: What treatment would you recommend for a patient with a PIK3CA mutation progressing after first-line ribociclib and an aromatase inhibitor?
The panel considers capivasertib, PI3K-pathway inhibitors, and newer regimens involving targeted agents and endocrine therapy. They emphasize that the decision depends on co-occurring ESR1 alterations, clinical context, drug availability, and patient preferences.
S19 Ep6: The Next Wave: ADCs, Targeted Therapies, and Emerging Strategies in Ovarian Cancer
Q: Can you talk about what cyclin E1 is, how it is measured or might be measured in the future, and the different treatments targeting it?
Cyclin E1 regulates cell-cycle progression, and high levels can create vulnerabilities around the G2M checkpoint and CDK2. Investigational WEE1 and CDK2 inhibitors have shown promising early activity; protein measurement by immunohistochemistry could become a companion diagnostic if validated.
S19 Ep6: The Next Wave: ADCs, Targeted Therapies, and Emerging Strategies in Ovarian Cancer
Q: What are the ADCs for ovarian cancer that you are most excited about for our patients with ovarian cancer, and when might these newer agents be available in the clinic?
Liu highlights several next-generation ADCs targeting folate receptor alpha, B7-H4, CDH6 and Trop-2. Early trials have shown encouraging activity, but response durability and timing of clinical availability depend on maturing data and ongoing trials.
S19 Ep9: Biology-Driven Care and AI Tools Steer the Future of Breast Oncology
Q: What are your thoughts about AI in breast oncology and also medical oncology today?
Abraham says AI is changing patient care and clinical work, and that health care professionals should learn about these tools and help guide their development to protect safety, quality, and patient-centeredness.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

A biomedical-focused interview series features in-depth conversations with academic oncologists and physician-recholers who dissect cutting-edge oncology data, trials, and therapeutic strategies. Topics span targeted therapies, antibody-drug conjugates, immunotherapy combinations, precision oncology, and novel delivery methods across solid tumors and hematologic malignancies. Episodes emphasize practical takeaways for clinical practice, real-world constraints, biomarker-driven decision-making, and the evolving treatment landscape presented at major conferences. A standout pattern is how guests translate complex trial results into actionable insights for clinicians, with recurring attention to safety signals, sequencing, patient quality of l... more

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncLive® On Air?

These podcasts share a similar audience with OncLive® On Air:

1. Two Onc Docs
2. Oncology Brothers: Practice-Changing Cancer Discussions
3. Oncology Today with Dr Neil Love
4. Research To Practice | Oncology Videos
5. ASCO Daily News

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 8 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. David Carbone
2. Lyudmila Bazhenova
3. Sandip Patel
4. Jacob Sands
5. Triparna Sen
6. Erika P. Hamilton
7. Jame Abraham
8. Beth Faiman

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days